politics
Moderna mRNA flu vaccine to get FDA panel review
Why this matters: political developments that affect policy direction and public trust.
Moderna’s experimental mRNA flu shot will be reviewed by a Food and Drug Administration advisory panel next month, a move that suggests a more stable approach to drug reviews after the firing of former agency head Marty Makary. The panel will meet on June 18 to discuss and make recommendations on th
Read full story on The Hill → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop